DGAP-Adhoc: STRATEC's Board of Management proposes to raise

STRATEC Biomedical Systems AG / Dividend

06.03.2009 

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

STRATEC's Board of Management proposes to raise dividend by 59% to Euro
0.35 per share

Birkenfeld, March 6, 2009

In view of the future business performance expected at the STRATEC Group,
its high volume of liquidity and high equity ratio, the Board of Management
of STRATEC Biomedical Systems AG (FSE: SBS, Prime Standard Segment) today
resolved to present to the Supervisory Board a proposal for the
appropriation of profits for the Annual General Meeting which foresees
raising the dividend for the 2008 financial year by 59% to Euro 0.35 per
share (previous year: Euro 0.22).

---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

About STRATEC

STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de) designs
and manufactures fully automated analyzer systems for its partners in the
fields of clinical diagnostics and biotechnology. These partners market
such systems, in general together with their own reagents, to laboratories,
blood banks and research institutes around the world. The company develops
its products on the basis of its own patented technologies. Shares in the
company (ISIN: DE0007289001) are traded in the Prime Standard segment of
the Frankfurt Stock Exchange.

The STRATEC Group consists of the publicly listed parent company STRATEC
Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in
Germany, the USA, the UK, Switzerland and Romania.


Further information can be obtained from:

STRATEC Biomedical Systems AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Phone: +49 7082 7916 190
Fax: +49 7082 7916 999
Email: ir@stratec-biomedical.de
DGAP 06.03.2009 
---------------------------------------------------------------------------
Language:     English
Issuer:       STRATEC Biomedical Systems AG
              Gewerbestraße 37
              75217 Birkenfeld
              Deutschland
Phone:        +49 (0)7082 7916 0
Fax:          +49 (0)7082 7916 999
E-mail:       info@stratec-biomedical.de
Internet:     www.stratec-biomedical.de
ISIN:         DE0007289001
WKN:          728900
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Stuttgart, München, Düsseldorf
End of News                                     DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: STRATEC's Board of Management proposes to raise dividend by 59% to Euro 0.35 per share
